Showing results (151-160 of 2,778) with videos related to

Sort By:
Pageof 278
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Intra-articular osteoid osteoma at the elbow: report of a case and review of the literatureA Contreras, C Isasi, J Silveira, et al.
Neuroscience Letters|September 17, 2005
Enhanced ROS production and antioxidant defenses in cybrids harbouring mutations in mtDNACristofol Vives-Bauza, Ricardo Gonzalo, Giovanni Manfredi, et al.
Oncology Reports|June 19, 1998
Collecting duct carcinomas of the kidney: a comparative loss of heterozygosity study with clear cell renal cell carcinomaF Fogt, Z Zhuang, W M Linehan, et al.
Atencion Primaria|May 4, 2001
[Qualitative approach to the attitudes and expectations of doctors during the process of computerising primary care]C Calderón, R Rotaeche, C Carrera, et al.
Physical Review Letters|January 24, 2015
Haldane phase in the Hubbard model at 2/3-filling for the organic molecular compound Mo3S7(dmit)3C Janani, J Merino, I P McCulloch, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|May 1, 1995
Thiolprotease activity in skeletal and myocardial muscle and liver of fasted ratsA L Andreu, S Schwartz, J Asín, et al.
Physiological Research|January 1, 1993
Inhibition of visceral protein synthesis by certain amino acid supplementsS Schwartz, A L Andreu, E Garcia, et al.
Human Molecular Genetics|August 24, 2014
The ROS-sensitive microRNA-9/9* controls the expression of mitochondrial tRNA-modifying enzymes and is involved in the molecular mechanism of MELAS syndromeSalvador Meseguer, Ana Martínez-Zamora, Elena García-Arumí, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Increase in serum potassium caused by beta-2 adrenergic blockade in terminal renal failure: absence of mediation by insulin or aldosteroneP Arrizabalaga, J Montoliu, A Martinez Vea, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1986
Autoimmunity after induction of neonatal tolerance to alloantigens: role of B cell chimerism and F1 donor B cell activationS Luzuy, J Merino, H Engers, et al.
Pageof 278